Samantha Bowyer

Dr

  • The University of Western Australia (M503), 35 Stirling Highway,

    6009 Perth

    Australia

  • 43 Citations
  • 1 h-Index
20162018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Samantha Bowyer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Melanoma Medicine & Life Sciences
Antibodies Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Pneumonia Medicine & Life Sciences
Phase III Clinical Trials Medicine & Life Sciences
ipilimumab Medicine & Life Sciences
Treatment Failure Medicine & Life Sciences
Diarrhea Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2016 2018

  • 43 Citations
  • 1 h-Index
  • 2 Article
  • 1 Letter
1 Citation (Scopus)

Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''

Bowyer, S., Prithviraj, P., Lorigan, P., Larkin, J., McArthur, G., Atkinson, V., Millward, M., Khou, M., Diem, S., Ramanujam, S., Kong, B., Liniker, E., Guminski, A., Parente, P., Andrews, M. C., Parakh, S., Cebon, J., Long, G. V., Carlino, M. S. & Klein, O., 11 Apr 2017, In : British Journal of Cancer. 116, 8, p. e15

Research output: Contribution to journalLetter

Open Access
42 Citations (Scopus)

Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy

Bowyer, S., Prithviraj, P., Lorigan, P., Larkin, J., Mcarthur, G., Atkinson, V., Millward, M., Khou, M., Diem, S., Ramanujam, S., Kong, B., Liniker, E., Guminski, A., Parente, P., Andrews, M. C., Parakh, S., Cebon, J., Long, G. V., Carlino, M. S. & Klein, O., 2016, In : British Journal of Cancer. 114, 10, p. 1084-1089

Research output: Contribution to journalArticle

Open Access
Melanoma
Antibodies
Therapeutics
Pneumonia
Phase III Clinical Trials

Projects 2016 2016